Our results are in line with previous studies describing the prognostic value of HIF-1α and GLUT1 in patients with PDAC and PDHK1 in non-small cell lung cancer [[37], [38], [39]]. This evidence concerns the gene SLC2A1 and non-small cell lung carcinoma.